Small Pharma acquires U.S. patent for its DMT compounds

Mugglehead
By Rowan DunneOct 21, 2022, 9:03 pm255 pts
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) has been granted intellectual property protection for its dimethyltryptamine drugs. On Wednesday, the United Kingdom-based biotechnology company announced news of a second United States patent for its psychedelic portfolio. The patent will offer therapeutic…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Why Is Texas Supporting Psychedelics Research While Criminalizing Cannabis? (Op-Ed) 60

Blow Smoke, Not Your Cover with New Smokebuddy Bundles 47

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.